Last updated: 30 April 2024 at 6:27pm EST

Daniel Starks Net Worth




The estimated Net Worth of Daniel J Starks is at least $816 Milión dollars as of 26 October 2023. Mr. Starks owns over 50,000 units of Abbott Laboratories stock worth over $784,171,846 and over the last 8 years he sold ABT stock worth over $31,932,500. In addition, he makes $300,910 as Independent Director at Abbott Laboratories.

Mr. Starks ABT stock SEC Form 4 insiders trading

Daniel has made over 10 trades of the Abbott Laboratories stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of ABT stock worth $4,702,500 on 26 October 2023.

The largest trade he's ever made was exercising 504,544 units of Abbott Laboratories stock on 2 August 2017 worth over $15,938,545. On average, Daniel trades about 48,585 units every 126 days since 2017. As of 26 October 2023 he still owns at least 6,725,316 units of Abbott Laboratories stock.

You can see the complete history of Mr. Starks stock trades at the bottom of the page.





Daniel Starks biography

Daniel J. Starks serves as Independent Director of the Company. Mr. Starks served as the Chairman, President and Chief Executive Officer of St. Jude Medical, Inc. from 2004 until his retirement in January 2016, after which he served as its Executive Chairman of the Board until January 2017, when Abbott completed the acquisition of St. Jude Medical. Mr. Starks also served as President and Chief Operating Officer of St. Jude Medical from 2001 to 2004 and as its President and CEO, Cardiac Rhythm Management Business from 1997 to 2001. Having served as St. Jude Medical's Executive Chairman and its Chairman, President and Chief Executive Officer, and having joined St. Jude Medical in 1996, Mr. Starks contributes not only comprehensive and critical knowledge of St. Jude Medical's operations, but also extensive business and management experience operating a global public company in a highly regulated industry.

What is the salary of Daniel Starks?

As the Independent Director of Abbott Laboratories, the total compensation of Daniel Starks at Abbott Laboratories is $300,910. There are 22 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.



How old is Daniel Starks?

Daniel Starks is 65, he's been the Independent Director of Abbott Laboratories since 2017. There are 5 older and 36 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.

What's Daniel Starks's mailing address?

Daniel's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.

Insiders trading at Abbott Laboratories

Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez a Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.



What does Abbott Laboratories do?

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.



Complete history of Mr. Starks stock trades at Abbott Laboratories

Človek
Trans.
Transakcia
Celková cena
Daniel J Starks
Predaj $4,702,500
26 Oct 2023
Daniel J Starks
Predaj $5,688,000
27 Jul 2023
Daniel J Starks
Predaj $5,551,000
28 Apr 2023
Daniel J Starks
Predaj $4,873,000
27 Oct 2022
Daniel J Starks
Predaj $5,457,000
26 Jul 2022
Daniel J Starks
Predaj $5,661,000
3 May 2022
Daniel J Starks
Kúpa $24,348
27 Feb 2018
Daniel J Starks
Kúpa $1,795,997
27 Feb 2018
Daniel J Starks
Kúpa $2,429,045
27 Feb 2018
Daniel J Starks
Využitie opcie $15,938,545
2 Aug 2017


Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include: